QMS Medical Allied Services Limited (QMSMEDI)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 revenue grew 17.5% y-y to INR52.5 Cr; H1 FY27 revenue up 20% to INR109.4 Cr
- Services vertical targets INR180 Cr revenue in FY27 with 20-25% CAGR; merger with HCAH to create larger PSP platform
- Products vertical signed 5-year exclusive distribution with HEINE starting Jan 2027; aims to double HEINE revenue in 5 years
- BeamOptics acquisition to build indigenous R&D and manufacturing capabilities; transaction valuation pending
- EBITDA Q2 FY27 at INR6.5 Cr (12.4% margin); H1 FY27 EBITDA INR14.8 Cr (13.6% margin); PAT Q2 at INR2.4 Cr, H1 at INR6.4 Cr
- Employee expenses rose due to investments in people and technology; incremental costs backed by contracts
- Synergies from PSP merger expected operationally in FY28; legal approvals to take 12-13 months
- FY27 revenue guidance INR210-220 Cr; EBITDA guidance deferred pending Q3 results
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 QMSMEDI — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add QMSMEDI to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on QMS Medical Allied Services Limited
Important.
The summary above is generated automatically from QMS Medical Allied Services Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.